Masimo Corporation MASI announced preliminary revenues for the fourth quarter and full year 2025 on Monday. Despite the ...

Masimo Corporation MASI is well-poised for growth in the coming quarters, courtesy of its strong underlying demand for ...

Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ...

On January 12, 2026, Masimo announced select preliminary financial results for the fourth quarter and full year 2025, ahead of its full earnings release scheduled for February 26, 2026. For the fourth ...

Masimo (NASDAQ:MASI) supports medical monitoring innovation as nasdaq composite discussions include healthcare technology ...

The Irvine-based medical device maker expects Q4 revenue to increase 12% to $411 million and full year revenue to grow 9% to $1.5 billion.

Masimo Corporation's stock has underperformed, with shares down 6% versus SPY's 15% increase, due to mixed margins and lack of meaningful catalysts. The company's financials show low ROA, ROE, and ...

Good afternoon, ladies and gentlemen, and welcome to Masimo's Fourth Quarter and Full Year 2024 Earnings Conference Call. The company's press release is available at www.masimo.com. At this time, all ...

Irvine-based medical device maker Masimo Corp. today announced that it has entered into an agreement to sell its Sound United consumer audio business to Harman International, a wholly owned subsidiary ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund declined 5.06% ...

The company's bottom line came in at $44.9 million, or $0.82 per share. This compares with $24.8 million, or $0.46 per share, last year. Excluding items, Masimo Corporation reported adjusted earnings ...